BioSpace News Archive

Spectrum Therapeutics (“Spectrum”), the medical division of Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) (the “Company” or “Canopy Growth”) is pleased to announce a partnership with the Canadian Mental Health Association (“CMHA”).

New microbroth dilution plates provide gold standard-level(1) minimum inhibitory concentration (MIC) accuracy using first- and second-line treatment options

Healthcare groups under one roof; poised for enhanced collaboration

This is the First-in-Human Implementation for Geneos Therapeutics’ Exquisitely Personalized Immunotherapies for Cancer (GT-EPIC) Platform Clinical collaboration with Washington University

Successful pilot demonstrates potential new option for delivering medicines and vaccines in hard-to-reach locations and during emergencies. Additional tests planned.

Named best “Independent Software Vendor” at 10th annual TAG Southeastern Software Association ceremony

Respicardia Also Initiates 500-Patient Prospective, Global, Single-Arm Longitudinal Study

AtriCure will host a conference call at 4:30 p.m. Eastern Time on Tuesday, July 30, 2019 to discuss its second quarter 2019 financial results

Battelle is combining years of brain-computer interface projects, such as NeuroLife®, with its expertise in machine learning and artificial intelligence under a new award from the federal government’s forward-thinking government agency, the Defense Advanced Research Projects Agency.

IDT Biologika announced that the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, an agency of the United States Department of Health and Human Services, has awarded the company a new Task Order within the 10-year Indefinite Delivery, Indefinite Quantity contract no.